AzTrials
AzTrials

StrokeNCT01356654

Transcranial Direct Current Stimulation in Stroke Rehabilitation

A study testing Application of Transcranial direct current stimulation (TDCS) and Transcranial Direct current stimulation in people with Stroke, run by Universiteit Antwerpen at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study investigates if transcranial Direct Current Stimulation (tDCS) is effective in the recovery of postural control in stroke rehabilitation. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke
What is being tested?
Application of Transcranial direct current stimulation (TDCS) and Transcranial Direct current stimulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
34 participants
Where
1 siteBelgium
Study dates
Mar 2010to Jun 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients suffering from the consequences of a stroke in the medial cerebral artery, during the sub-acute phase (4-24 weeks after onset)
  • Age between 18-75 years
  • Hospitalised in rehabilitation Hospital Hof Ter Schelde
  • Capable of understanding and giving informed consent

Who cannot join

  • Cerebellum or brainstem lesions
  • Recently multiple lesions and older lesions which are manifested clinically.
  • History of severe substance abuse (alcohol, drugs, benzodiazepines)
  • Cardiac disease that in the opinion of the clinician precludes participation in the trial (severe dyspnea in rest, severe rhythm disturbances, etc)
  • History of epileptic insults, not caused by the stroke
  • Severe organic co morbidity
Show all 9Show fewer
  • Psychiatric disorders or history of psychiatric disorders
  • Pace maker / internal defibrillator
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

Belgium1 site, 1 recruiting
  • Rehabilitation Hospital Hof Ter Schelde

    Antwerp, Antwerp, 2050

    Wim Saeys, MSc, 032106020, wim.saeys@hotmail.com

    Wim Saeys, Msc

    Recruiting

Other trials in Belgium

About this study

Official title: The Use of Transcranial Direct Current Stimulation in the Recovery of Postural Control in Stroke

This study investigates if transcranial Direct Current Stimulation (tDCS) is effective in the recovery of postural control in stroke rehabilitation.

Read the detailed description

The patients were divided in 2 groups by a randomisation procedure. All patients participated for 2 months in the study. Group 1 received true tDCS in the first month followed by SHAM stimulation in the second month. Group 2 received SHAM in the first month and true stimulation in the following month. Four stimulations of 20minutes were provided during 4 weeks before before changing stimulation intensity.

Conditions
Stroke
Being tested
Application of Transcranial direct current stimulation (TDCS), Transcranial Direct current stimulation
Keywords
Stroke, TDCS, Gait, Balance, loss of postural balance
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Application of Transcranial direct current stimulation (TDCS)Device

    Also called tDCS device: CESta, Mind Alive Inc.,Edmonton, Alberta, Canada

    Application of TDCS for 20 minutes, 4 times a week for 4 weeks.

  • Transcranial Direct current stimulationDevice

    Also called tDCS device: CESta, Mind Alive Inc., Edmonton, Alberta, Canada

    Application of true TDCS for 20min, 4 times a week for 4 weeks.

Study groups in NCT01356654
Study groupRoleWhat they receive
SHAM TDCSSham comparatorNot described
Receives: Device: Application of Transcranial direct current stimulation (TDCS)
True TDCSActive comparatorNot described
Receives: Device: Transcranial Direct current stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Trunk Impairment Scale (reporting a change on trunk performance at baseline, after 1 month and after two months)

    The static sitting balance subscale assesses whether a subject can sit independently and remain seated when the legs are either passively or actively crossed. The dynamic sitting balance subscale evaluates the ability to actively shorten each side of the trunk, first initiated from the shoulder and subsequently initiated from the pelvic girdle. Trunk coordination is evaluated by the possibility to independently rotate the upper and lower part of the trunk. The scoring range for the static and dynamic sitting balance and coordination subscales are 7, 10 and 6 points respectively.

    Measured: baseline, after 1 month, After 2 months

  2. Rivermead Motor Assessment Battery (RMAB) (reporting a change on motricity of gross function, arm, leg and trunk at baseline, after 1 month and after two months)

    The RMAB assesses the motor performance of patients with stroke.32 It consists of test items clustered in three sections that are ordered hierarchically. The gross function subscale (13 items), the Leg and Trunk subscale (10 items) and the arm subscale (15 items)

    Measured: baseline, after 1 month, After 2 months

  3. Tinetti Test (reporting a change on balance and gait tasks at baseline, after 1 month and after two months)

    The Tinetti Test is an easily performed test that measures a patients' gait and balance. The individual scores are combined to form three measures; a gait score, a standing balance score and a total score.

    The maximum score for the gait component and the balance component are 12 and 16 points respectively, resulting in a maximum of 28 points for the total score.

    Measured: baseline, after 1 month, After 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2011 (estimated)
  2. Study startMar 2010
  3. Primary completionJun 2011 (estimated)
  4. Study completionJun 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
34 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01356654
Sponsor's protocol ID
Saeys-1
Status last verified
May 2011
First submitted
10 May 2011
Last updated
19 May 2011
Results posted
No
Data monitoring committee
Yes

Publications

  • Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke. Cochrane Database Syst Rev. 2020 Nov 11;11(11):CD009645. doi: 10.1002/14651858.CD009645.pub4.

    PubMed 33175411

Questions about this trial

What is this clinical trial studying?

A study testing Application of Transcranial direct current stimulation (TDCS) and Transcranial Direct current stimulation in people with Stroke, run by Universiteit Antwerpen at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 May 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Trunk Impairment Scale (reporting a change on trunk performance at baseline, after 1 month and after two months) (time frame: baseline, after 1 month, After 2 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01356654, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in